Skip to main content
CDC Website

Hepatitis

Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office

This journal article is a practice guideline that provides recommendations summarizing the growing literature and current best practices of chronic Hepatitis C Virus (HCV) treatment, including treatment in difficult-to-treat populations. These recommendations are based on an extensive review of published data, national consensus recommendations, and input from thought leaders involved in HCV care and treatment.

MMWR: Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone - Indiana, 2015

This report summarizes an ongoing investigation of an HIV infection community outbreak linked to injection drug users of oxymorphone in Indiana. It presents information on 135 people who have been diagnosed since January in a small rural area that normally sees no more than five cases annually. The report discusses the state's response to contain the spread of HIV and hepatitis C.

HCSP Fact Sheet: Alcohol and HCV

This information sheet discusses why it is important to abstain from alcohol after being diagnosed with with hepatitis C virus (HCV), especially for patients undergoing antiviral therapy. It states that patients who drink during HCV treatment are less likely to clear the virus. The fact sheet gives tips to check for alcohol abuse and has a table with information on different types of liquor.

Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis - Stakeholders' Workbook: Exploring Vital Roles and Opportunities to Break the Silence

This workbook contains an initial list of opportunities that stakeholders from various sectors can undertake to complement the federal efforts detailed in the 100-page Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis. It was created to assist organizations and stakeholders in identifying additional innovative and actionable (specific and detailed) opportunities to advance each of the Action Plan’s six priority areas. This workbook accompanies the Action Plan found at: https://www.aids.gov/pdf/viral-hepatitis-action-plan.pdf.

HCSP Fact Sheet: Hepatitis E (HEV)

This information sheet explains hepatitis E virus (HEV), which is mainly transmitted via a fecal-oral route due to contaminated water supplies, but other sources of infection have been identified. The fact sheet discusses transmission, prevention, symptoms, risk factors, and prevalence in the United States.

HCSP Fact Sheet: Hepatitis C and U.S. Hispanics

This information sheet explains that the number of Hispanics with hepatitis C (2.6%) is higher than the number of people with hepatitis C in the general population (1.3%). It also states that hepatitis C disease progression has been shown to be faster in Hispanics than in non-Hispanic whites. The fact sheet describes treatment of hepatitis C, which has been found to be as effective in Hispanics as it is in other groups.

HCSP Fact Sheet: An Overview of Extrahepatic Manifestations of Hepatitis C

This information sheet discusses extrahepatic manifestation, which means diseases or conditions that affect organs other than the liver when someone has hepatitis C virus (HCV). It explains how extrahepatic manifestations of hepatitis C can be found in the skin, eyes, joints, immune system, nervous system and kidneys. The fact sheet provides a list of these conditions and states that some of these conditions are more common and well-documented, while others are infrequent or their association with hepatitis C has not yet been proven.

HCSP Fact Sheet: Hepatitis A (HAV): What You Need to Know

This information sheet describes hepatitis A, a disease of the liver caused by the hepatitis A virus (HAV), which is a picornavirus that enters the blood stream via the intestines. It explains that HAV is the most common type of viral hepatitis in the United States with an estimated 3,000 new infections annually. It discusses prevention, transmission, symptoms, treatment and the HAV vaccine.